CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-01 | Hidalgo Medina Manuel Director | Grant or award · Deferred Share Units | +2,807.81 | $71.23 | $200K | 8,769.48 |
| 2022-12-31 | Haller Julia A Director | Grant or award · Deferred Share Units | +469.08 | $71.95 | $34K | 16,826.22 |
| 2022-12-31 | Arduini Peter J Director | Grant or award · Deferred Share Units | +469.08 | $71.95 | $34K | 40,485.58 |
| 2022-12-31 | Hidalgo Medina Manuel Director | Grant or award · Deferred Share Units | +117.27 | $71.95 | $8K | 5,914.35 |
| 2022-12-31 | YALE PHYLLIS R Director | Grant or award · Deferred Share Units | +469.08 | $71.95 | $34K | 16,568.22 |
| 2022-12-31 | Samuels Theodore R. II Director | Grant or award · Deferred Share Units | +677.55 | $71.95 | $49K | 34,624.14 |
| 2022-12-31 | Bhatt Deepak Director | Grant or award · Deferred Share Units | +104.24 | $71.95 | $7K | 1,990.78 |
| 2022-12-31 | Storch Gerald L Director | Grant or award · Deferred Share Units | +503.82 | $71.95 | $36K | 74,040.14 |
| 2022-12-31 | Rice Derica W Director | Grant or award · Deferred Share Units | +503.82 | $71.95 | $36K | 12,588.62 |
| 2022-12-02 | BOERNER CHRISTOPHER S. EVP, Chief Commercial Officer | Option exercise | +2,637 | 44,603 | ||
| 2022-12-02 | BOERNER CHRISTOPHER S. EVP, Chief Commercial Officer | Shares withheld for taxes | −1,349 | $81.13 | $109K | 43,254 |
| 2022-12-02 | BOERNER CHRISTOPHER S. EVP, Chief Commercial Officer | Option exercise · Restricted Stock Units | −2,637 | 2,638 | ||
| 2022-12-02 | Elkins David V EVP, Chief Financial Officer | Option exercise | +8,792 | 128,578 | ||
| 2022-12-02 | Elkins David V EVP, Chief Financial Officer | Shares withheld for taxes | −4,498 | $81.13 | $365K | 124,080 |
| 2022-12-02 | Elkins David V EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −8,792 | 8,792 | ||
| 2022-12-02 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +8,792 | 65,871 | ||
| 2022-12-02 | VESSEY RUPERT EVP, Research & Early Dev. | Shares withheld for taxes | −4,498 | $81.13 | $365K | 61,373 |
| 2022-12-02 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise · Restricted Stock Units | −8,792 | 8,792 | ||
| 2022-11-09 | Powell Ann EVP, Chief Human Resources | Sale | −16,250 | $80.45 | $1.3M | 34,226.09 |
| 2022-11-07 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +5,843 | $70.89 | $414K | 56,228 |
Page 53 of 56 · 1,112 trades